• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMR
Click for more information
0.00% 45.5¢

IMRICOR MEDICAL SYSTEMS INC. - News & Media

Market Cap $92.16M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging... Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices, which is used to carry out real-time interventional Cardiac Magnetic Resonance Imaging (iCMR) cardiac ablation procedures. The Company is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The Company sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.More

Articles & Videos

Imricor (ASX:IMR) sees modest gains as company steps closer to EU trial

Imricor Systems' shares were up 2.17% in lunchtime trades on news the company is one step closer to launching a medical trial in Switzerland.

08 Mar 2024 12:39 (AEDT)

Imricor grows Middle Eastern operations with MRI heart tech to hit Qatar

Provider of interventional Cardiac Magnetic Resonance (iCMR) ablation medical hardware Imricor Medical Systems (ASX:IMR) has just expanded its Middle Eastern presence.

20 Dec 2023 13:46 (AEDT)

Imricor Medical Systems (ASX:IMR) partners with GE HealthCare for heart ablation procedures

Imricor Medical Systems (ASX:IMR) has partnered with global meditech giant GE Healthcare to perform real-time heart ablations using a mix of both companies' technologies.

27 Jan 2023 17:15 (AEDT)

US FDA gives Imricor Medical Systems (ASX:IMR) green light to begin VISABL-ALF trial

Imricor Medical Systems (ASX:IMR) has been granted Investigational Device Exception (IDE) approval from the US Food and Drug Administration (FDA) to begin a clinical trial in the United States.

24 Jan 2023 17:46 (AEDT)



(20min delay)
Last
45.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $92.16M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 162409 45.5¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 25000 1
View Market Depth
Last trade - 16.12pm 15/05/2024 (20 minute delay) ?
IMR (ASX) Chart

Top Stories

Want copper with that? Boss Energy hits orange metal on-site uranium play

The exploration team at Boss Energy announced on Wednesday that its latest drill run on-site has successfully found copper.
Recce Pharma heading closer to full efficacy data for flagship R327 Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial has been dosed.
Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing Sun Silver is enjoying a strong debut on the local bourse with shares up 100% to 40cps as miners enjoy budgetary stimulus.
Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management Industry specialist Shekel Brainweigh (ASX:SBW) has built AI into its high-tech product scale and weighing technologies.
Market Close: Materials win on critical minerals, hydrogen budget promises Renascor Resources (ASX:RNU) was the biggest winner gaining 30 per cent without market news, while Chalice Mining (ASX:CHN), Vulcan Energy Resources (ASX:VUL) and Aeris Resources (ASX:AIS) all gained between 7 and 10 per cent.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.